For the development of this software, Clinilabs provided support to AMPS from clinical and core laboratory perspectives. The first installation of TrialPerfect was conducted at Clinilabs.
The combination of TrialPerfect and CalECG is expected to offer a safe client/server environment for the storage, analysis, interpretation, validation, and review of ECG traces in the context of clinical trials.
Gary Zammit, president and CEO of Clinilabs, said: “TrialPerfect enables us to efficiently handle ECG data obtained from single-center studies to large, multicenter clinical trials.
“This application, along with Clinilabs’s proprietary methods, allows us to offer exceptional service at competitively low cost to pharmaceutical and biotechnology companies that expect only the best.”